Bone-Differentiation-Associated Circ-Spen Regulates Death of Mouse Bone Marrow Mesenchymal Stem Cells by Inhibiting Apoptosis and Promoting Autophagy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25053034 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ziwen Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, National Natural Science Foundation of China.
Abstract (Originalsprache)
The role of estrogen receptor β (ERβ) in bone health is closely associated with its function in vivo, and ERβ−/− mice have been widely utilized to explore the related influences. In this study, ERβ−/− female mice were established to investigate the differential expression of circular RNAs (circRNAs) by RNA-Sequencing (RNA-Seq). Among these circRNAs, mmu_circ_0011379 (named Circ-Spen) exhibited high expression in ERβ−/− female mice. However, the precise mechanism by which Circ-Spen regulates bone health remained unclear. This study identified Circ-Spen as a positive regulator of mouse bone marrow mesenchymal stem cell (mBMSC) viability. The expression of Circ-Spen was markedly increased in ERβ−/− mice femurs tested by RT-qPCR. Moreover, Circ-Spen exhibited an enhanced expression during the bone formation process of mBMSCs. Qualitative experiments also demonstrated that Circ-Spen possessed a circular structure and was localized within the nucleus of mBMSCs. Functionally, it inhibited apoptosis via caspase-3, BCL-2, and BAX, while also promoting autophagy through BECN1 and P62 in mBMSCs tested by MTT assays, transmission electron microscopy (TEM), and Western blotting. These findings reveal the potential of targeting Circ-Spen as a promising therapeutic strategy for rejuvenating senescent mBMSCs and enhancing the efficiency of mBMSC transplantation, which lays the foundation for advancements in the field of bone therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Jinan University, Guangzhou 510632, China.
- Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Guangzhou 510632, China.
- College of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Xiaoyun Li
Förderung
- National Key Research and Development Program of China
- Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Liang, Z., Luo, B., Peng, B., Li, Y., Hu, X., Zhong, W., Li, X., Wang, P., Zhu, X., Zhang, R., & Yang, L. (2024). Bone-Differentiation-Associated Circ-Spen Regulates Death of Mouse Bone Marrow Mesenchymal Stem Cells by Inhibiting Apoptosis and Promoting Autophagy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053034
Vancouver
Liang Z, Luo B, Peng B, Li Y, Hu X, Zhong W, et al. Bone-Differentiation-Associated Circ-Spen Regulates Death of Mouse Bone Marrow Mesenchymal Stem Cells by Inhibiting Apoptosis and Promoting Autophagy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053034
BibTeX
@article{Liang2024,
author = {Liang, Ziwen and Luo, Bingjie and Peng, Bojia and Li, Yunchuan and Hu, Xueling and Zhong, Wenqiang and Li, Xiaoyun and Wang, Panpan and Zhu, Xiaofeng and Zhang, Ronghua and Yang, Li},
title = {Bone-Differentiation-Associated Circ-Spen Regulates Death of Mouse Bone Marrow Mesenchymal Stem Cells by Inhibiting Apoptosis and Promoting Autophagy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25053034}
}
EUVIMED